Migraine Awareness Month: The Challenges Facing Headache Research
In honor of National Migraine and Headache Awareness Month, the Will Erwin Headache Research Foundation has dedicated the entire month of June to spreading awareness about debilitating headaches. Debilitating headaches, including migraines and cluster headaches, are...
Migraine Awareness Month June 2022
Each year, June is recognized as Migraine Awareness Month, with the goal of furthering awareness about debilitating headaches and informing the public of these headache disorders. As part of this mission, The Will Erwin Headache Research Foundation has produced this...
Migraine Awareness Month: The Infancy of Headache Research
The Will Erwin Headache Research Foundation was founded with the mission to find a cure for debilitating headaches. We hope to achieve this mission through our continued research on headache disorders, their causes, and possible treatment options. Each year, June is...
Post-Traumatic Headaches
Post-concussion, or post-traumatic, headaches are one of the most common symptoms of a concussion. Many patients report that this type of headache is distinctly different from a normal one, likely because its causes and presentations are different. Post-concussion...
Natural Supplement Provides Hope For Chronic Headache Sufferers
Natural Supplement Provides Hope For Chronic Headache Sufferers The Will Erwin Headache Research Foundation was founded to find a cure for cluster headaches and migraines, increase awareness about the different types of debilitating headaches, and the available...
Migraine and Pregnancy
The Will Erwin Headache Research Foundation was founded with the mission to find a cure for cluster headaches and migraines as well as increase awareness about the different types of debilitating headaches and the lives of sufferers, and the available treatment...
Trudhesa: New Acute Migraine Treatment
Trudhesa: New Acute Migraine Treatment The Will Erwin Headache Research Foundation was founded with the mission to find a cure for cluster headaches and migraines as well as increase awareness about the different types of debilitating headaches and the lives of...
New Preventative Migraine Medication QULIPTA Gets Approval From FDA
New Preventative Migraine Medication QULIPTA Gets Approval From FDA Towards the end of 2021, a breakthrough has been made in the migraine research space as the U.S. FDA approved the use of a preventative treatment called QULIPTA. QULITPA In September 2021, the U.S....
The Preventative Power of Nurtec
The Preventative Power of Nurtec and the Fight Against Migraines Migraines are more than just a "mild inconvenience" according to one recent study - they've become the third most prevalent illness in the world. The same source indicated that nearly one out of every...
Migraine Treatment and COVID-19 Vaccines
As COVID-19 vaccines have become available — including Pfizer, Moderna, and Johnson & Johnson — many individuals who experience migraines and other headache disorders have wondered if those vaccines will impact their current, or potential, migraine treatments....
IN THIS SECTION
We have teamed up with the Memorial Hermann Health System and The University of Texas Health Science Center at the McGovern Medical School.
The Will Erwin Headache Research Foundation is a 501(c)(3) tax exempt organization founded in 2014. Our tax ID is 46-4886305. For more information, contact us at jferwin@cureheadaches.org or 713-238-9100, or contact the Greater Houston Community Foundation at 713-333-2245.